CY1109733T1 - Χρησιμοποιηση πολυαιθυλενο γλυκολης για τη θεραπεια παθησεων ασθενειων και τραυματων, που εχουν σχεση με φλεγμονη - Google Patents

Χρησιμοποιηση πολυαιθυλενο γλυκολης για τη θεραπεια παθησεων ασθενειων και τραυματων, που εχουν σχεση με φλεγμονη

Info

Publication number
CY1109733T1
CY1109733T1 CY20101100050T CY101100050T CY1109733T1 CY 1109733 T1 CY1109733 T1 CY 1109733T1 CY 20101100050 T CY20101100050 T CY 20101100050T CY 101100050 T CY101100050 T CY 101100050T CY 1109733 T1 CY1109733 T1 CY 1109733T1
Authority
CY
Cyprus
Prior art keywords
treatment
glyclis
polythylene
injuries
diagnosis
Prior art date
Application number
CY20101100050T
Other languages
English (en)
Inventor
Den Plas Dave Van
Smet Kris De
Philippe Sollie
Original Assignee
Flen Pharma N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flen Pharma N.V. filed Critical Flen Pharma N.V.
Publication of CY1109733T1 publication Critical patent/CY1109733T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η παρούσα εφεύρεση αφορά συνθέσεις ή υδατικά διαλύματα, που περιέχουν μια ή περισσότερες μορφές πολυαιθυλένο γλυκόλης, για χρησιμοποίηση ως φαρμάκων, ειδικότερα για τοπική εφαρμογή κατά την θεραπευτική αγωγή τραυμάτων, κατά την θεραπευτική αγωγή φλεγμονωδών δερματικών ασθενειών και ειδικότερα για την πρόληψη σχηματισμού ουλής και/ή την ενίσχυση της αποκατάστασης βλαβέντος δέρματος ή βλεννογόνου.
CY20101100050T 2006-07-28 2010-01-18 Χρησιμοποιηση πολυαιθυλενο γλυκολης για τη θεραπεια παθησεων ασθενειων και τραυματων, που εχουν σχεση με φλεγμονη CY1109733T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0615016.3A GB0615016D0 (en) 2006-07-28 2006-07-28 Use of polyethylene glycol in inflammation related topical disorders or diseases and wound healing
EP07801465A EP1988909B1 (en) 2006-07-28 2007-07-30 Use of polyethylene glycol in inflammation related topical disorders or diseases and wound healing

Publications (1)

Publication Number Publication Date
CY1109733T1 true CY1109733T1 (el) 2014-09-10

Family

ID=37006336

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100050T CY1109733T1 (el) 2006-07-28 2010-01-18 Χρησιμοποιηση πολυαιθυλενο γλυκολης για τη θεραπεια παθησεων ασθενειων και τραυματων, που εχουν σχεση με φλεγμονη

Country Status (17)

Country Link
US (1) US20090317474A1 (el)
EP (1) EP1988909B1 (el)
AT (1) ATE446098T1 (el)
AU (1) AU2007278428B2 (el)
BR (1) BRPI0715361B8 (el)
CA (1) CA2657718C (el)
CY (1) CY1109733T1 (el)
DE (1) DE602007002884D1 (el)
DK (1) DK1988909T3 (el)
ES (1) ES2335555T3 (el)
GB (1) GB0615016D0 (el)
NZ (1) NZ574479A (el)
PL (1) PL1988909T3 (el)
PT (1) PT1988909E (el)
RU (1) RU2009107068A (el)
SI (1) SI1988909T1 (el)
WO (1) WO2008012107A2 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201508961VA (en) * 2013-05-29 2015-12-30 Otsuka Pharma Co Ltd Adhesion preventing material
US9393278B2 (en) * 2013-06-26 2016-07-19 Han Sheng Biotech Co., Ltd. Method for wound healing
GB2540054B (en) 2014-04-30 2017-07-12 Matoke Holdings Ltd Antimicrobial compositions
US10045885B2 (en) * 2015-09-24 2018-08-14 Medline Industries, Inc. Wound dressing materials and methods of making thereof
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
CN108969531B (zh) * 2018-01-18 2020-12-11 中南大学湘雅医院 聚乙二醇作为活性成分在制备银屑病治疗药物中的应用及其药物
EP3934753A1 (en) * 2019-03-04 2022-01-12 Capretto EHF. Microbial removal

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3226753A1 (de) * 1982-07-14 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Wundverband zur aufnahme von wundsekret
US6940864B2 (en) * 2001-07-16 2005-09-06 International Business Machines Corporation Network access traffic sorter
DE10153023A1 (de) * 2001-10-26 2003-05-15 Beiersdorf Ag Wirkstoffhaltige kosmetische Reinigungsemulsionen
US6809231B2 (en) * 2001-11-21 2004-10-26 The United States Of America As Represented By The Secretary Of Agriculture Flexible and absorbent alginate wound dressing
JP2003212773A (ja) * 2002-01-04 2003-07-30 Oramon Arzneimittel Gmbh セチリジン及びロラタジンの局所医薬組成物
US7737182B2 (en) * 2002-08-09 2010-06-15 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals for xerosis
FR2887149B1 (fr) * 2005-06-17 2007-08-03 Galderma Sa Procede de solubilisation du metronidazole

Also Published As

Publication number Publication date
AU2007278428B2 (en) 2012-08-16
PL1988909T3 (pl) 2010-06-30
RU2009107068A (ru) 2010-09-10
BRPI0715361B1 (pt) 2020-01-07
PT1988909E (pt) 2010-01-25
BRPI0715361B8 (pt) 2021-05-25
WO2008012107A2 (en) 2008-01-31
DE602007002884D1 (de) 2009-12-03
ATE446098T1 (de) 2009-11-15
AU2007278428A1 (en) 2008-01-31
EP1988909A2 (en) 2008-11-12
SI1988909T1 (sl) 2010-02-26
ES2335555T3 (es) 2010-03-29
EP1988909B1 (en) 2009-10-21
CA2657718C (en) 2014-09-09
WO2008012107A3 (en) 2008-03-27
NZ574479A (en) 2011-05-27
GB0615016D0 (en) 2006-09-06
BRPI0715361A2 (pt) 2013-06-18
CA2657718A1 (en) 2008-01-31
DK1988909T3 (da) 2010-02-08
US20090317474A1 (en) 2009-12-24

Similar Documents

Publication Publication Date Title
CY1109733T1 (el) Χρησιμοποιηση πολυαιθυλενο γλυκολης για τη θεραπεια παθησεων ασθενειων και τραυματων, που εχουν σχεση με φλεγμονη
CY1118661T1 (el) Φαρμακευτικη συνθεση, φαρμακευτικη δοσολογικη μορφη, διαδικασια για την παρασκευη τους, μεθοδοι για αντιμετωπιση και χρησεις αυτων
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
WO2008139122A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
NO20083780L (no) Topisk sammensetning omfattende en antibakteriell substans
GT200900095A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas.
WO2009040420A3 (en) Use of a monoterpene to increase tissue repair
CY1111454T1 (el) Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων
EA202091303A3 (ru) Композиция ингибитора jak для местного применения
WO2009109618A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1
ATE448232T1 (de) Substituierte heterozyklen
WO2009109616A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40
WO2009109654A8 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
ECSP088745A (es) Derivados sustituidos de cromanol y su uso
WO2012050831A3 (en) Combination treatment for dermatological conditions
CY1116840T1 (el) Χρηση 24-norudca
FR2978665B1 (fr) Composition antiseptique
GT201300125A (es) 1h-pirazol-5-olato sódico sustituido
CY1116938T1 (el) Αναπληρωτικη θεραπεια της ασθενειας huntington και αλλων ασθενειων πολυγλουταμiνης
TN2015000282A1 (fr) Composition dermatologique antimicrobienne topique
CY1114760T1 (el) Θεραπευτικη αγωγη αθηροσκληρωσης
DE602006009259D1 (de) Pharmazeutische zusammensetzung mit einem organopoirkstoff
DE602006020155D1 (de) Pharmazeutische wundheilungs-zusammensetzungen in ren und natriumhyaluronat
EA200800537A1 (ru) Маррубиин и композиция для уменьшения храпа, упаковка и методика
BRPI0620983B8 (pt) uso de derivados de triazina para fabricação de um medicamento, e composição farmacêutica para uso tópico